You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study

Citation Tools

Article menu
Clinical care/Education/Nutrition
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Niwaha AJ, Rodgers LR, Carr ALJ, et al
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study
BMJ Open Diabetes Research and Care 2022;10:e002714. doi: 10.1136/bmjdrc-2021-002714